Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Asset Utilization Ratio (2016 - 2025)

Ptc Therapeutics has reported Asset Utilization Ratio over the past 13 years, most recently at 0.62 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.62 for Q4 2025, up 78.63% from a year ago — trailing twelve months through Dec 2025 was 0.62 (up 78.63% YoY), and the annual figure for FY2025 was 0.75, up 67.78%.
  • Asset Utilization Ratio for Q4 2025 was 0.62 at Ptc Therapeutics, down from 0.67 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for PTCT hit a ceiling of 0.73 in Q1 2025 and a floor of 0.19 in Q1 2021.
  • Median Asset Utilization Ratio over the past 5 years was 0.42 (2022), compared with a mean of 0.45.
  • Biggest five-year swings in Asset Utilization Ratio: crashed 41.18% in 2024 and later skyrocketed 78.63% in 2025.
  • Ptc Therapeutics' Asset Utilization Ratio stood at 0.27 in 2021, then soared by 55.97% to 0.43 in 2022, then soared by 39.58% to 0.59 in 2023, then crashed by 41.18% to 0.35 in 2024, then skyrocketed by 78.63% to 0.62 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.62 (Q4 2025), 0.67 (Q3 2025), and 0.67 (Q2 2025) per Business Quant data.